Physician profile
Marc Campbell
NPI 1134416126
$15,030.46
in general payments reported to CMS, 2019-2025
30 companies · $2,578 in 2025
The $2,578 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,298 · 2020: $197 · 2021: $5,126 · 2022: $20.92 · 2023: $44.03 · 2024: $1,766 · 2025: $2,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Food and Beverage | $887.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,136.44 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $98.24 | 2025 | Ribfix Blu Advantage |
| Acera Surgical, INC. | $89.92 | 2024-2025 | Restrata Wound Matrix |
| Medtronic, INC. | $69.63 | 2024-2025 | Absorbatack, Maxtack |
| Portola Pharmaceuticals, LLC | $46.91 | 2019 | |
| Pfizer INC. | $41.92 | 2019 | |
| Tela Bio, INC. | $37.67 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mimedx Group, INC. | $36.42 | 2025 | |
| Allergan, INC. | $34.55 | 2019 | |
| Merck Sharp & Dohme LLC | $33.16 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.25 | 2023-2024 | Xifaxan |
| Elucent Medical | $29.98 | 2025 | |
| Abbvie INC. | $28.80 | 2023 | Mavyret |
| Astrazeneca Pharmaceuticals LP | $27.23 | 2024 | Imfinzi |
| Baxter Healthcare | $26.70 | 2025 | Perclot |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $25.85 | 2019 | |
| Kls-Martin L.P. | $24.53 | 2019 | |
| Dilon Technologies, INC. | $21.24 | 2025 | Hemoblast Bellows |
| Smith+Nephew, INC. | $20.90 | 2019 | |
| Z-Medica, LLC | $20.34 | 2020 | |
| Cardinal Health 414 LLC | $19.71 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.14 | 2019 | |
| Capsovision, INC. | $16.91 | 2024 | Capsocam Plus |
| Acell, INC. | $15.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.79 | 2019 | |
| Shire North American Group INC | $13.87 | 2019 | |
| Teleflex LLC | $13.86 | 2024 | Deknatel |
| Olympus America INC. | $13.54 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.93 | 2019 | |
| Applied Medical Technology INC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.